Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-03-20

Clinical Trial Update: Rate of Change of HbA1c (dx/dt) May Predict Progression to Type 2 DM

View source ↗

Summary

A terminated clinical trial explored whether the rate of HbA1c change over time (dx/dt) can predict progression to Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Wyckoff Heights Medical Center | Conditions: Diabetes Mellitus Type 2 | Status: TERMINATED